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Background
Women are particularly at risk of HIV infection and there
is an urgent need for female-controlled approaches to
block the heterosexual transmission of HIV.
Material and Methods
Our work is aimed at the development of a simple, cost-
effective, female-controlled preventative against hetero-
sexual transmission of HIV in women, based on our pre-
vious proof-of-concept study employing a natural
component of the vaginal microflora, as a delivery vehicle
for the anti-HIV protein (PNAS, 2003, 100:11672-
11677).
Results
A human vaginal isolate of Lactobacillus jensenii was engi-
neered, by stable integration of an optimized expression
cassette into the bacterial genome, to secrete high levels of
the highly potent HIV inhibitor, CV-N. The L. jensenii-
expressed CV-N dramatically decreases infectivity of
CCR5-tropic HIVBaL and CXCR4-tropic HIVIIIB in vitro. We
further demonstrate that this strain is genetically stable
and can transiently colonize animal vaginal mucosa,
while retaining important characteristics of the native bac-
terial phenotype.
Conclusion
This live microbicide represents a novel approach in the
development of an inexpensive and stable protein-based
microbicide to curtail the HIV/AIDS pandemic world-
wide.
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